Liver transplantation for neuroendocrine tumors in Europe - Results and trends in patient selection: A 213-case European liver transplant registry study

Annals of Surgery

Volumn 257, Issue 5, 2013, Pages 807-815

  Le Treut, Yves Patrice ^a   Grégoire, Emilie ^a   Klempnauer, Jürgen ^b   Belghiti, Jacques ^c   Jouve, Elisabeth ^a   Lerut, Jan ^d   Castaing, Denis ^e   Soubrane, Olivier ^f   Boillot, Olivier ^g   Mantion, Georges ^h   Homayounfar, Kia ⁱ   Bustamante, Manuel ^j   Azoulay, Daniel ^k   Wolf, Philippe ^l   Krawczyk, Marek ^m   Pascher, Andreas ⁿ   Suc, Bertrand ^o   Chiche, Laurence ^p   De Urbina, Jorge Ortiz ^q   Mejzlik, Vladimir ^r   Pascual, Manuel ^s   Lodge, J Peter A ^t   Gruttadauria, Salvatore ^u   Paye, François ^v   Pruvot, François René ^w   Thorban, Stefan ^x   Foss, Aksel ^y   Adam, René ^e   more..

^a AIX MARSEILLE UNIVERSITY   (France)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c BEAUJON HOSPITAL   (France)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^e HÔPITAL PAUL BROUSSE   (France)

^f Hôpital Cochin ^*  (France)

^g EDOUARD HERRIOT HOSPITAL   (France)

^h UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

ⁱ UNIVERSITY OF GÖTTINGEN   (Germany)

^j HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^k HENRI MONDOR HOSPITAL   (France)

^l HÔPITAL DE HAUTEPIERRE   (France)

^m MEDICAL UNIVERSITY OF WARSAW   (Poland)

ⁿ CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^o CHU RANGUEIL   (France)

^p CHU CÔTE DE NACRE   (France)

^q HOSPITAL DE CRUCES   (Spain)

^r Center of Cardiovascular Surgery and Transplantations   (Czech Republic)

^s LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^t ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^u MEDITERRANEAN INSTITUTE FOR TRANSPLANTATION AND ADVANCED SPECIALIZED THERAPIES ISMETT   (Italy)

^v HÔPITAL SAINT ANTOINE   (France)

^w LILLE UNIVERSITY HOSPITAL   (France)

^x TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^y OSLO UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

liver transplantation; multivariate analysis; neuroendocrine tumors; prognostic study

Indexed keywords

ACUTE PANCREATITIS; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CHRONIC GRAFT REJECTION; COHORT ANALYSIS; DISEASE FREE SURVIVAL; FEMALE; HEPATIC ARTERY THROMBOSIS; HEPATOMEGALY; HORMONE RELEASE; HUMAN; LIVER METASTASIS; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NEUROENDOCRINE TUMOR; OVERALL SURVIVAL; PATIENT SELECTION; PERITONITIS; PORTAL VEIN THROMBOSIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURGICAL MORTALITY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; EUROPE; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROENDOCRINE TUMORS; PATIENT SELECTION; PROGNOSIS; REGISTRIES; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84876296931     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31828ee17c     Document Type: Article

References (32)

1. Pape UF, Böhming M, Berndt U, et al. Survival and clinical outcome of patients with neuroendocrine tumors of the gastroenteropancreatic tract in a German referral center. Ann NY Acad Sci. 2004;1014:222-233.
2. Hentic O, Couvelard A, Rebours V, et al. Ki-67 index, tumor differentiation, and extent of liver involvement are independent prognostic factors in patients with liver metastases of digestive endocrine carcinomas. Endocr Relat Cancer. 2010;18:51-59
3. Pavel M, Baudin E, Couvelard A, et al. ENETS Consensus Guidelines for the management of patients with liver and others distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology. 2012;95:157-176.
4. Rindi G, Arnold R, Bosman FT. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. In: Bosman FT, Carneiro F, Hruban H, Theise ND, eds. WHO Classification of Tumours of the Digestive System. Lyon: IARC Press; 2010:13-14.
5. Mazzaferro V. Surgical approach to the treatment of liver metastases from neuroendocrine tumors: hepatic resection and liver transplantation. Tumori. 2010;96:833-846.
6. Mazzaferro V, Pulvirenti A, Coppa J. Neuroendocrine tumors metastatic to the liver: how to select patients for liver transplantation? J Hepatol. 2007;47:460-466.
7. Florman S, Toure B, Kim L, et al. Liver transplantation for neuroendocrine tumors. J Gastrointest Surg. 2004;8:208-212.
8. Frilling A, Malago M, Weber F, et al. Liver transplantation for patients with metastatic endocrine tumors: single-center experience with 15 patients. Liver Transpl. 2006;12:1089-1096.
9. Marin C, Robles R, Fernandez JA, et al. Role of liver transplantation in the management of unresectable neuroendocrine liver metastases. Transplant Proc. 2007;39:2302-2303.
10. Olausson M, Friman S, Herlenius G, et al. Orthotopic liver or multivis-ceral transplantation as treatment of metastatic neuroendocrine tumors. Liver Transpl. 2007;13:327-333.
11. Rosenau J, Bahr MJ, von Wasielewski R, et al. Ki67, E-cadherin, and p53 as prognostic indicators of long-term outcome after liver transplantation for metastatic neuroendocrine tumors. Transplantation. 2002;73: 386-394.
12. Routley D, Ramage JK, McPeake J, et al. Orthotopic liver transplantation in the treatment of metastatic neuroendocrine tumors of the liver. Liver Transpl Surg. 1995;1:118-121.
13. van Vilsteren FG, Baskin-Bey ES, Nagorney DM, et al. Liver transplantation for gastroenteropancreatic neuroendocrine cancers: defining selection criteria to improve survival. Liver Transpl. 2006;12:448-456.
14. Alessiani M, Tzakis A, Todo S, et al. Assessment of five-year experience with abdominal organ cluster transplantation. J Am Coll Surg. 1995;180:1-9.
15. Le Treut YP, Delpero JR, Dousset B, et al. Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg. 1997;225:355-364.
16. Le Treut YP, Gregoire E, Belghiti J, et al. Predictors of long-term survival after liver transplantation for metastatic endocrine tumors: an 85-case French multicentric report. Am J Transplant. 2008;8:1205-1213.
17. Lehnert T. Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation. 1998;66:1307-1312.
18. Gedaly R, Daily MF, Davenport D, et al. Liver transplantation for the treatment of liver metastases from neuroendocrine tumors: an analysis of the UNOS database. Arch Surg. 2011;146:953-958.
19. N'Guyen NT, Harring TR, Goss JA, et al. Neuroendocrine liver metastases and orthotopic liver transplantation: the US experience. Int J Hepatol. 2011:742890. doi: 10.4061/2011/742890.
20. Vauthey JN, Abdalla EK, Doherty DA, et al. Body surface area and body weight predict total liver volume in western adults. Liver Transpl. 2002;8:233-240.
21. Starzl TE, Todo S, Tzakis A. Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg. 1989;210:374-385.
22. O'Grady JG. Treatment options for other hepatic malignancies. Liver Transpl. 2000;6:S23-S29.
23. Moertel CG. An Odyssey in the land of small tumor. J Clin Oncol. 1987;5:1503-1522.
24. Soreide O, Berstad T, Bakka A, et al. Surgical treatment as a principle in patients with advanced abdominal carcinoids tumors. Surgery. 1992;111:48-54.
25. Yao JC, Hassan M, Phan A, et al. One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35, 825 cases in United States. J Clin Oncol. 2008;26:3063-3072.
26. Durante C, Boukheris H, Dromain C, et al. Prognostic factors influencing survival from metastatic (stage IV) gastroenteropancreatic well-differentiated endocrine carcinoma. Endocr Relat Cancer. 2009;16:585-597.
27. Sutcliffe R, Maguire D, Ramage J, et al. Management of neuroendocrine liver metastases. Am J Surg. 2004;187:39-46.
28. Sher L. Association between timing of resection of primary tumor in patients undergoing liver transplantation for metastatic neuroendocrine tumor and survival. Am J Transplant. 2009;12:88.
29. Pascher A, Klupp J, Neuhaus P. Endocrine tumours of the gastrointestinal tract. Transplantation in the management of metastatic endocrine tumours. Best Pract Res Clin Gastroenterol. 2005;19:637-648.
30. Grégoire E, Le Treut YP. Liver transplantation for primary and secondary endocrine tumors. Transplant Int. 2010;23:704-711.
31. Bonnacorsi-Riani E, Apestegui C, Jouret-Mourin A, et al. Liver transplantation and neuroendocrine tumors: lessons from a single centre experience and from the literature review. Transplant Int. 2010;23:668-678.
32. Frilling A, Li J, Malamutmann E, et al. Treatment of liver metastases from neuroendocrine tumours in relation to the extent of hepatic disease. Br J Surg. 2009;96:175-184.